Nima Baradaran1, Lindsay A Hampson1, Todd C Edwards2, Bryan B Voelzke3, Benjamin N Breyer4,5. 1. Department of Urology, University of California - San Francisco, San Francisco, CA, USA. 2. Department of Health Services, Seattle Quality of Life Group, University of Washington, Seattle, WA, USA. 3. Department of Urology, University of Washington - Harborview Medical Center, Seattle, WA, USA. 4. Department of Urology, University of California - San Francisco, San Francisco, CA, USA. Benjamin.Breyer@ucsf.edu. 5. Zuckerberg San Francisco General Hospital and Trauma Center, University of California - San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA. Benjamin.Breyer@ucsf.edu.
Abstract
PURPOSE OF REVIEW: Treatment of anterior urethral stricture disease (USD) has shifted from endoscopic approaches to urethroplasty with significantly higher success rates among reconstructive urologists. This academic stance has led to a critical evaluation of "success" and developing disease-specific instruments to assess surgical outcomes focusing on patients' satisfaction rather than the historical goal of avoiding secondary procedures. RECENT FINDINGS: Many disease non-specific and/or non-validated patient-reported outcome measures (PROMs) have been utilized to evaluate the voiding symptoms and sexual of function of patients after urethroplasty in the literature. Urethral Stricture Surgery PROM (USS PROM) is the first validated, disease-specific PROM for anterior USD which has been designed in 2001. Urethral Stricture Symptoms and Impact Measure (USSIM) is a comprehensive PROM and is currently being validated at multiple institutions. This article reviews the tools used to assess success after urethroplasty and elaborates the need to develop a comprehensive USD-specific PROM.
PURPOSE OF REVIEW: Treatment of anterior urethral stricture disease (USD) has shifted from endoscopic approaches to urethroplasty with significantly higher success rates among reconstructive urologists. This academic stance has led to a critical evaluation of "success" and developing disease-specific instruments to assess surgical outcomes focusing on patients' satisfaction rather than the historical goal of avoiding secondary procedures. RECENT FINDINGS: Many disease non-specific and/or non-validated patient-reported outcome measures (PROMs) have been utilized to evaluate the voiding symptoms and sexual of function of patients after urethroplasty in the literature. Urethral Stricture Surgery PROM (USS PROM) is the first validated, disease-specific PROM for anterior USD which has been designed in 2001. Urethral Stricture Symptoms and Impact Measure (USSIM) is a comprehensive PROM and is currently being validated at multiple institutions. This article reviews the tools used to assess success after urethroplasty and elaborates the need to develop a comprehensive USD-specific PROM.
Authors: Bradley A Erickson; Michael A Granieri; Joshua J Meeks; Kevin T McVary; Christopher M Gonzalez Journal: J Urol Date: 2010-05-16 Impact factor: 7.450
Authors: Rachel A Mann; Ramón Virasoro; Jessica M DeLong; Rafael E Estrella; Merycarla Pichardo; Ramón Rodríguez Lay; Gustavo Espino; Joshua D Roth; Sean P Elliott Journal: Can Urol Assoc J Date: 2021-02 Impact factor: 1.862
Authors: Andrew J Cohen; German Patino; Mehran Mirramezani; Sudarshan Srirangapatanam; Anas Tresh; Bhagat Cheema; Jenny Tai; Dylan Romero; Anthony Enriquez; Laurence S Baskin; Shawn C Shadden; Benjamin N Breyer Journal: PLoS One Date: 2020-11-11 Impact factor: 3.240
Authors: Malte W Vetterlein; Almut Gödde; Luis A Kluth; Valentin Zumstein; Philipp Gild; Phillip Marks; Armin Soave; Christian P Meyer; Silke Riechardt; Roland Dahlem; Margit Fisch Journal: World J Urol Date: 2021-03-11 Impact factor: 4.226